1. Home
  2. DNA vs NRC Comparison

DNA vs NRC Comparison

Compare DNA & NRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNA
  • NRC
  • Stock Information
  • Founded
  • DNA 2008
  • NRC 1981
  • Country
  • DNA United States
  • NRC United States
  • Employees
  • DNA N/A
  • NRC N/A
  • Industry
  • DNA Biotechnology: Biological Products (No Diagnostic Substances)
  • NRC Biotechnology: Commercial Physical & Biological Resarch
  • Sector
  • DNA Health Care
  • NRC Health Care
  • Exchange
  • DNA Nasdaq
  • NRC Nasdaq
  • Market Cap
  • DNA 423.5M
  • NRC 426.3M
  • IPO Year
  • DNA N/A
  • NRC N/A
  • Fundamental
  • Price
  • DNA $7.17
  • NRC $19.12
  • Analyst Decision
  • DNA Hold
  • NRC
  • Analyst Count
  • DNA 6
  • NRC 0
  • Target Price
  • DNA $37.80
  • NRC N/A
  • AVG Volume (30 Days)
  • DNA 1.2M
  • NRC 83.8K
  • Earning Date
  • DNA 11-12-2024
  • NRC 10-25-2024
  • Dividend Yield
  • DNA N/A
  • NRC 2.48%
  • EPS Growth
  • DNA N/A
  • NRC N/A
  • EPS
  • DNA N/A
  • NRC 1.12
  • Revenue
  • DNA $217,951,000.00
  • NRC $144,155,000.00
  • Revenue This Year
  • DNA N/A
  • NRC N/A
  • Revenue Next Year
  • DNA $12.85
  • NRC N/A
  • P/E Ratio
  • DNA N/A
  • NRC $17.33
  • Revenue Growth
  • DNA N/A
  • NRC N/A
  • 52 Week Low
  • DNA $5.26
  • NRC $17.62
  • 52 Week High
  • DNA $75.20
  • NRC $42.19
  • Technical
  • Relative Strength Index (RSI)
  • DNA 45.31
  • NRC 47.87
  • Support Level
  • DNA $6.01
  • NRC $18.62
  • Resistance Level
  • DNA $6.68
  • NRC $21.64
  • Average True Range (ATR)
  • DNA 0.76
  • NRC 0.81
  • MACD
  • DNA -0.14
  • NRC 0.01
  • Stochastic Oscillator
  • DNA 28.45
  • NRC 23.87

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering and BiosecurityThe majority of revenue in the company comes from the Biosecurity segment, which charges fees for data analytics and services.

About NRC National Research Corporation (Delaware)

National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.

Share on Social Networks: